| scholarly article | Q13442814 |
| P50 | author | Eric O Freed | Q67208349 |
| P2093 | author name string | Kunio Nagashima | |
| Benjamin G Luttge | |||
| Ferri Soheilian | |||
| Mary Ann Checkley | |||
| P2860 | cites work | Virus maturation as a new HIV-1 therapeutic target | Q24642446 |
| Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production | Q27485930 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Q29619254 | ||
| The structural biology of HIV assembly | Q30437103 | ||
| Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease | Q30850215 | ||
| Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging | Q30980940 | ||
| A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly | Q33782377 | ||
| Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations. | Q33785977 | ||
| Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain | Q33805303 | ||
| Ultrastructure of HIV/AIDS. | Q34847845 | ||
| In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat). | Q35139703 | ||
| Molecular characterization of feline immunodeficiency virus budding | Q36483903 | ||
| Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. | Q36632356 | ||
| Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | Q36650046 | ||
| In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
| Human immunodeficiency virus type 1 assembly, release, and maturation. | Q36857103 | ||
| Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation | Q36944553 | ||
| PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing | Q37089562 | ||
| HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. | Q37447762 | ||
| Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. | Q39579012 | ||
| N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles | Q39580545 | ||
| Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. | Q39685850 | ||
| The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity | Q39870242 | ||
| The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. | Q40042979 | ||
| Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein | Q40059062 | ||
| Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly | Q41047831 | ||
| Proteolytic processing and particle maturation | Q41100821 | ||
| Image reconstructions of helical assemblies of the HIV-1 CA protein | Q41631451 | ||
| A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle | Q42546287 | ||
| A conformational switch controlling HIV-1 morphogenesis | Q42690194 | ||
| HIV-1 gag proteins: diverse functions in the virus life cycle | Q43783202 | ||
| Assembly and analysis of conical models for the HIV-1 core. | Q52228420 | ||
| Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease | Q69564852 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 137-144 | |
| P577 | publication date | 2010-02-20 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation | |
| P478 | volume | 400 |
| Q41730903 | A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro |
| Q40618525 | A Truncated Nef Peptide from SIVcpz Inhibits the Production of HIV-1 Infectious Progeny |
| Q35531477 | A genetic interaction between the core and NS3 proteins of hepatitis C virus is essential for production of infectious virus |
| Q39214476 | A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells |
| Q27324263 | Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors |
| Q33761008 | Cryo electron tomography of native HIV-1 budding sites |
| Q35201628 | Crystal structure of an antiviral ankyrin targeting the HIV-1 capsid and molecular modeling of the ankyrin-capsid complex |
| Q90182295 | Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice |
| Q92623235 | Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes |
| Q36434250 | Elucidation of the Molecular Mechanism Driving Duplication of the HIV-1 PTAP Late Domain |
| Q34237075 | Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications |
| Q27309923 | Fusion of mature HIV-1 particles leads to complete release of a gag-GFP-based content marker and raises the intraviral pH |
| Q28533696 | Gag-Pol processing during HIV-1 virion maturation: a systems biology approach |
| Q34594538 | HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes |
| Q24614498 | HIV type 1 Gag as a target for antiviral therapy |
| Q58597952 | HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites |
| Q38366763 | HIV-1 gag: an emerging target for antiretroviral therapy. |
| Q34529834 | HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice |
| Q57050142 | High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation |
| Q57459053 | Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation |
| Q35832693 | Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice. |
| Q30832180 | In vitro protease cleavage and computer simulations reveal the HIV-1 capsid maturation pathway |
| Q30613887 | Maturation of the HIV-1 core by a non-diffusional phase transition. |
| Q28076138 | My Cousin, My Enemy: quasispecies suppression of drug resistance |
| Q40732172 | RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly |
| Q50355158 | Recent advances in retroviruses via cryo-electron microscopy. |
| Q36667936 | Reevaluation of the requirement for TIP47 in human immunodeficiency virus type 1 envelope glycoprotein incorporation |
| Q38393674 | Retroviral proteases and their roles in virion maturation |
| Q26752271 | Retrovirus maturation-an extraordinary structural transformation |
| Q92490664 | Second Generation Inhibitors of HIV-1 Maturation |
| Q33769181 | Structural analysis of HIV-1 maturation using cryo-electron tomography |
| Q28828191 | Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396 |
| Q35024116 | Targeting the HIV entry, assembly and release pathways for anti-HIV gene therapy |
| Q27009643 | The choreography of HIV-1 proteolytic processing and virion assembly |
| Q52339521 | Transmission genetics of drug-resistant hepatitis C virus. |
Search more.